Practical Considerations for Biosimilars

Practical Considerations for Biosimilars is organized by Connect Educate Impact (CEI).

Initial Release Date: October 1, 2022
Planned Expiration Date: October 1, 2025

Objectives:
Upon successful completion of this course, learners should be able to:
• Discuss common barriers to biosimilar use
• Develop strategies to improve patient access to care through the use of biosimilars
• Review factors that impact the regulation of biosimilar use
• Identify relevant state-based guidance for managing biosimilar switching and substituting
• Recognize the unique properties of insulin that make it difficult to replicate and manufacture. 
• Evaluate the use of interchangeable biosimilar insulin in a pharmacy practice setting.